By Susan Heavey
WASHINGTON (Reuters) – U.S. deaths from the coronavirus pandemic have surged past 2,000 for two days in a row as the most dangerous season of the year approached, taxing an overwhelmed healthcare system with U.S. political leadership in disarray.
The toll from COVID-19 reached its second-highest level ever on Wednesday with 2,811 lives lost, according to a Reuters tally of official data, one short of the record from April 15.
Nearly 200,000 new U.S. cases were reported on Wednesday, with record hospitalizations approaching 100,000 patients.
The sobering data came as the head of the U.S. Centers for Disease Control and Prevention on Wednesday warned that December, January and February were likely to be “the most difficult time in the public health history of this nation.”
CDC Director Dr. Robert Redfield told an event hosted by the U.S. Chamber of Commerce that the United States could start losing around 3,000 people – roughly the number that died in the attacks of Sept. 11, 2001 – each day over the next two months.
“The mortality concerns are real and I do think unfortunately before we see February, we could be close to 450,000 Americans that have died from this virus,” Redfield said. The U.S. death toll since the start of the pandemic stands at around 273,000.
Hospitals are filling up with COVID-19 patients, reducing care for people needing treatment for other ailments. Redfield said 90% of U.S. hospitals were in areas designated as coronavirus “hot zones.”
Rural and suburban hospitals were particularly affected, threatening their economic viability, Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, told MSNBC on Thursday.
“There’s no end in sight because there’s so much community spread,” Adalja said, warning that the pandemic could force hospital closures.
Still, rapid vaccine development, aided by the Trump administration’s “Operation Warp Speed” program, offered a ray of hope.
Britain on Wednesday gave emergency approval to Pfizer Inc’s COVID-19 vaccine, a sign that U.S. regulators may soon follow suit and allow inoculations within weeks.
(Reporting by Susan Heavey and Daniel Trotta; Writing by Daniel Trotta; Editing by Bernadette Baum)
